IN
Information not explicitly listed on homepage
CEO/Management (implied by 'core team' section)
TenNor TherapeuticsRoles
Therapeutic Areas
TenNor Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TNP-2198 (利福特尼唑) | Helicobacter pylori infection | Phase 3 |
| Pipeline program | Implantable medical device-related infections | Not specified (likely clinical) |